vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and VICOR CORP (VICR). Click either name above to swap in a different company.
VICOR CORP is the larger business by last-quarter revenue ($113.0M vs $83.1M, roughly 1.4× PROCEPT BioRobotics Corp). VICOR CORP runs the higher net margin — 18.3% vs -38.1%, a 56.3% gap on every dollar of revenue. On growth, VICOR CORP posted the faster year-over-year revenue change (20.2% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 14.7%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Vicor Corporation is a manufacturer of power modules headquartered in Andover, Massachusetts.
PRCT vs VICR — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $83.1M | $113.0M |
| Net Profit | $-31.6M | $20.7M |
| Gross Margin | 64.9% | — |
| Operating Margin | -4.1% | 59.7% |
| Net Margin | -38.1% | 18.3% |
| Revenue YoY | 20.2% | 20.2% |
| Net Profit YoY | -27.9% | 713.9% |
| EPS (diluted) | $-0.56 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $83.1M | $113.0M | ||
| Q4 25 | $76.4M | $107.3M | ||
| Q3 25 | $83.3M | $110.4M | ||
| Q2 25 | $79.2M | $96.0M | ||
| Q1 25 | $69.2M | $94.0M | ||
| Q4 24 | $68.2M | $96.2M | ||
| Q3 24 | $58.4M | $93.2M | ||
| Q2 24 | $53.4M | $85.9M |
| Q1 26 | $-31.6M | $20.7M | ||
| Q4 25 | $-29.8M | $46.5M | ||
| Q3 25 | $-21.4M | $28.3M | ||
| Q2 25 | $-19.6M | $41.2M | ||
| Q1 25 | $-24.7M | $2.5M | ||
| Q4 24 | $-18.9M | $10.2M | ||
| Q3 24 | $-21.0M | $11.6M | ||
| Q2 24 | $-25.6M | $-1.2M |
| Q1 26 | 64.9% | — | ||
| Q4 25 | 60.6% | 55.4% | ||
| Q3 25 | 64.8% | 57.5% | ||
| Q2 25 | 65.4% | 95.9% | ||
| Q1 25 | 63.9% | 47.2% | ||
| Q4 24 | 64.0% | 52.4% | ||
| Q3 24 | 63.2% | 49.1% | ||
| Q2 24 | 59.0% | 49.8% |
| Q1 26 | -4.1% | 59.7% | ||
| Q4 25 | -40.6% | 14.6% | ||
| Q3 25 | -27.8% | 18.9% | ||
| Q2 25 | -28.0% | 47.3% | ||
| Q1 25 | -39.7% | -0.2% | ||
| Q4 24 | -28.9% | 9.6% | ||
| Q3 24 | -38.4% | 5.8% | ||
| Q2 24 | -50.3% | 0.2% |
| Q1 26 | -38.1% | 18.3% | ||
| Q4 25 | -39.1% | 43.4% | ||
| Q3 25 | -25.7% | 25.6% | ||
| Q2 25 | -24.7% | 42.9% | ||
| Q1 25 | -35.8% | 2.7% | ||
| Q4 24 | -27.6% | 10.7% | ||
| Q3 24 | -35.9% | 12.4% | ||
| Q2 24 | -48.0% | -1.4% |
| Q1 26 | $-0.56 | $0.44 | ||
| Q4 25 | $-0.54 | $1.01 | ||
| Q3 25 | $-0.38 | $0.63 | ||
| Q2 25 | $-0.35 | $0.91 | ||
| Q1 25 | $-0.45 | $0.06 | ||
| Q4 24 | $-0.34 | $0.24 | ||
| Q3 24 | $-0.40 | $0.26 | ||
| Q2 24 | $-0.50 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.6M | $404.2M |
| Total DebtLower is stronger | $51.7M | — |
| Stockholders' EquityBook value | $347.7M | $754.1M |
| Total Assets | $487.1M | $804.9M |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.6M | $404.2M | ||
| Q4 25 | $286.5M | $402.8M | ||
| Q3 25 | $294.3M | $362.4M | ||
| Q2 25 | $302.7M | $338.5M | ||
| Q1 25 | $316.2M | $296.1M | ||
| Q4 24 | $333.7M | $277.3M | ||
| Q3 24 | $196.8M | $267.6M | ||
| Q2 24 | $214.1M | $251.9M |
| Q1 26 | $51.7M | — | ||
| Q4 25 | $51.6M | — | ||
| Q3 25 | $51.6M | — | ||
| Q2 25 | $51.5M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | $51.4M | — | ||
| Q2 24 | $51.4M | — |
| Q1 26 | $347.7M | $754.1M | ||
| Q4 25 | $365.9M | $711.6M | ||
| Q3 25 | $380.3M | $630.1M | ||
| Q2 25 | $385.8M | $608.6M | ||
| Q1 25 | $389.2M | $580.3M | ||
| Q4 24 | $402.2M | $570.1M | ||
| Q3 24 | $241.2M | $554.6M | ||
| Q2 24 | $251.8M | $537.2M |
| Q1 26 | $487.1M | $804.9M | ||
| Q4 25 | $508.1M | $785.8M | ||
| Q3 25 | $511.5M | $710.2M | ||
| Q2 25 | $513.1M | $693.5M | ||
| Q1 25 | $519.4M | $665.0M | ||
| Q4 24 | $534.0M | $641.1M | ||
| Q3 24 | $374.1M | $632.8M | ||
| Q2 24 | $374.4M | $613.2M |
| Q1 26 | 0.15× | — | ||
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
VICR
| Product revenue | $98.0M | 87% |
| Royalty revenue | $15.0M | 13% |
